We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page
Stock ticker: | ZTS |
Name: | ZOETIS INC. |
Sector: | Healthcare |
Investing Risk: | MEDIUM |
Forecast length: | 7 days |
Accuracy: | 24.34 % |
Average profit per target: | 8.53 % |
Signal Date | Signal Price | Date Reached | Price Reached | Profit | Direction |
---|---|---|---|---|---|
2022-08-18 | 165.56 $ | 2023-12-13 | 194.23 $ | 17.31% | |
2024-04-09 | 164.82 $ | 2024-04-19 | 144.88 $ | 12.1% | |
2024-05-14 | 167 $ | 2024-08-06 | 183.68 $ | 9.98% | |
2024-05-21 | 170.88 $ | 2024-09-09 | 190.06 $ | 11.23% | |
2024-05-28 | 169.4 $ | 2024-09-16 | 192.56 $ | 13.67% | |
2024-06-04 | 169.98 $ | 2024-09-09 | 190.06 $ | 11.81% | |
2024-06-18 | 167.78 $ | 2024-09-09 | 190.06 $ | 13.28% | |
2024-06-25 | 166.12 $ | 2024-09-17 | 194 $ | 16.79% | |
2025-02-26 | 164.44 $ | 2025-04-08 | 143.92 $ | 12.47% | |
2025-02-28 | 166.68 $ | 2025-04-08 | 143.92 $ | 13.65% | |
2025-03-27 | 164.47 $ | 2025-04-08 | 143.92 $ | 12.49% |
ProShare Advisors LLC recently sold a significant number of shares in Zoetis Inc. (NYSE: ZTS), indicating a change in their investment strategy. Zoetis Inc....
On February 26, 2025, QuantWave, the automated forecasting platform, issued a short signal for Zoetis Inc. stock (ZTS) with a price of $164.44....
On March 27, 2025, QuantWave issued a short signal for ZOETIS INC. with the stock trading at 164.47 $. The forecast proved to be accurate as the price target of 143....
QuantWave, an automated forecasting platform, successfully reached its price target forecast for Zoetis Inc., generating a profit of 13.65%....
Zoetis Inc., a leading global animal health company, has caught the attention of investors as Xponance Inc. recently acquired 2814 shares of its stock....
Zoetis Inc. (NYSE:ZTS) has been gaining attention from investors as short interest in the company continues to rise....
Hedge funds have shown great interest in Zoetis Inc. (NYSE:ZTS) as the best pharma stock to buy....
Zoetis Inc., a leading animal health company, has recently announced a higher return on equity (ROE) compared to its industry peers....
Zoetis Inc., a leading global animal health company, has recently reported a higher return on equity (ROE) compared to its industry counterparts....
Zoetis Inc., a leading animal health company, has recently surpassed industry expectations by delivering a remarkable Return on Equity (ROE) performance....